Schroder Investment Management Group Tandem Diabetes Care Inc Transaction History

Schroder Investment Management Group

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$53.22 - $123.09 $3.41 Million - $7.88 Million	-64,026 Reduced 63.22%	37,242 $2.24 Million
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $4.18 Million - $6.16 Million	41,015 Added 68.07%	101,268 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $395,430 - $512,640	3,346 Added 5.88%	60,253 $9.07 Million
Q3 2021 Nov 12, 2021	BUY	$93.51 - $129.4 $383,391 - $530,540	4,100 Added 7.76%	56,907 $6.79 Million
Q2 2021 Aug 13, 2021	BUY	$77.0 - $100.19 $4.07 Million - $5.29 Million	52,807 New	52,807 $5.14 Million
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $112,314 - $213,484	-2,371 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$53.13 - $71.19 $125,971 - $168,791	2,371 New	2,371 $141,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.